Unknown

Dataset Information

Continuation of anticoagulation through ambulatory phlebectomy does not impact postoperative bleeding risk.


ABSTRACT:

Objectives

Chronic anticoagulation for atrial fibrillation, a history of venous thromboembolism, and after heart valve replacement is often stopped or bridged for surgery. Our institutional practice is to continue anticoagulation through ambulatory phlebectomy (AP) procedures. As such, we aimed to compare postprocedure bleeding and major adverse events in patients on anticoagulation who received AP compared with patients not on anticoagulation.

Methods

We included all patients who required AP from January 2016 to February 2023. Given the low frequency of chronic anticoagulation during the study period, as defined as patients on anticoagulation ≥30 days before index procedure and not held through the procedure, a propensity score match of 16 demographic parameters was perform

SUBMITTER: Cleary CM 

PROVIDER: S-EPMC11891725 | biostudies-literature | 2025 Jan

REPOSITORIES: biostudies-literature